Are nonnucleoside analogue-based regimens better than protease inhibitor-based regimens for nonadherent HIV-infected patients?

被引：4
|
作者：
Knobel, H [1 ]
机构：
[1] Univ Autonoma Barcelona, Hosp Mar, Dept Internal Med Infect Dis, Barcelona 08003, Spain
来源：
CLINICAL INFECTIOUS DISEASES | 2005年 / 40卷 / 01期
关键词：
D O I：
10.1086/426596
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：164 / 166
页数：3
相关论文
共 50 条
  • [1] Protease Inhibitor-Based Regimens Are Associated with Inferior Outcomes in HIV-Infected Kidney Transplant Recipients
    Shelton, B.
    Sawinski, D.
    Reed, R.
    MacLennan, P.
    Mehta, S.
    Locke, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 263 - 264
  • [2] The Impact of Protease Inhibitor-Based Antiretroviral Regimens On Renal Transplant Outcomes in HIV-Infected Recipients
    Sparkes, T.
    Manitpisitkul, W.
    Masters, B.
    Pickard, M.
    Amoroso, A.
    Davis, C.
    Mavanur, M.
    Bartlett, S.
    Haririan, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 187 - 188
  • [3] Characterization of low level viraemia in HIV-infected patients receiving boosted protease inhibitor-based antiretroviral regimens
    Ferretti, Francesca
    Mackie, Nicola E.
    Singh, Gurmit Kaur Jagjit
    Fox, Julie
    Kaye, Steve
    McClure, Myra O.
    Taylor, Graham
    Boffito, Marta
    [J]. HIV RESEARCH & CLINICAL PRACTICE, 2019, 20 (4-5) : 107 - 110
  • [4] The Impact of Protease Inhibitor-Based Antiretroviral Regimens On Renal Transplant Outcomes in HIV-Infected Recipients.
    Sparkes, T.
    Manitpisitkul, W.
    Masters, B.
    Pickard, M.
    Amoroso, A.
    Davis, C.
    Mavanur, M.
    Bartlett, S.
    Haririan, A.
    [J]. TRANSPLANTATION, 2014, 98 : 187 - 188
  • [5] Protease inhibitor-based regimens for HIV therapy - Safety and efficacy
    Walmsley, Sharon
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 : S5 - S13
  • [6] Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens
    Martini, Salvatore
    Pisaturo, Mariantonietta
    Russo, Antonio
    Palamone, Maria Grazia
    Russo, Maria Teresa
    Zollo, Verdiana
    Maggi, Paolo
    Coppola, Nicola
    [J]. PATHOGENS, 2023, 12 (07):
  • [7] Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children
    Abadi, J
    Sprecher, E
    Rosenberg, MG
    Dobroszycki, J
    Sansary, J
    Fennelly, G
    Wiznia, A
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (03) : 298 - 303
  • [8] Gut Bacterial Communities in HIV-Infected Individuals with Metabolic Syndrome: Effects of the Therapy with Integrase Strand Transfer Inhibitor-Based and Protease Inhibitor-Based Regimens
    Baltazar-Diaz, Tonatiuh Abimael
    Amador-Lara, Fernando
    Andrade-Villanueva, Jaime F.
    Gonzalez-Hernandez, Luz Alicia
    Cabrera-Silva, Rodolfo Ismael
    Sanchez-Reyes, Karina
    Alvarez-Zavala, Monserrat
    Valenzuela-Ramirez, Aldo
    Del Toro-Arreola, Susana
    Bueno-Topete, Miriam Ruth
    [J]. MICROORGANISMS, 2023, 11 (04)
  • [9] Effectiveness and safety of protease inhibitor-based regimens in HIV-infected Thai children failing first-line treatment
    Wattanutchariya, N.
    Sirisanthana, V.
    Oberdorfer, P.
    [J]. HIV MEDICINE, 2013, 14 (04) : 226 - 232
  • [10] Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitor-based regimens in Asian HIV-infected children
    Bunupuradah, Torsak
    Puthanakit, Thanyawee
    Fahey, Paul
    Kariminia, Azar
    Yusoff, Nik K. N.
    Khanh, Truong H.
    Sohn, Annette H.
    Chokephaibulkit, Kulkanya
    Lumbiganon, Pagakrong
    Hansudewechakul, Rawiwan
    Razali, Kamarul
    Kurniati, Nia
    Huy, Bui V.
    Sudjaritruk, Tavitiya
    Kumarasamy, Nagalingeswaran
    Fong, Siew M.
    Saphonn, Vonthanak
    Ananworanich, Jintanat
    [J]. ANTIVIRAL THERAPY, 2013, 18 (04) : 591 - 598
12345